|
[1]HU XQ.Is liver biopsy the gold standard for assessment of liver fibrosis?[J].Chin J Hepatol, 2012, 20 (8) :568-570. (in Chinese) 胡锡琪.肝穿刺活组织检查是评估肝纤维化的金标准吗?[J].中华肝脏病杂志, 2012, 20 (8) :568-570.
|
|
[2]SEBASTIANI G.Non-invasive assessment of liver fibrosis in chronic liver diseases:implementation in clinical practice and decisional algorithms[J].World J Gastroenterol, 2009, 15 (18) :2190-2203.
|
|
[3]IMBERT-BISMUT F, RATZIU V, PIERONI L, et al.Biochemical markers of liver fibrosis in patients with hepatitis C virus infection:a prospective study[J].Lancet, 2001, 357 (9262) :1069-1075.
|
|
[4]FORNS X, AMPURDANS S, LLOVET JM, et al.Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model[J].Hepatology, 2002, 36 (4 Pt 1) :986-992.
|
|
[5]WAI CT, GREENSON JK, FONTANA RJ, et al.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology, 2003, 38 (2) :518-526.
|
|
[6] STERLING RK, LISSEN E, CLUMECK N, et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection[J].Hepatology, 2006, 43 (6) :1317-1325.
|
|
[7] ADAMS LA, BULSARA M, ROSSI E, et al.Hepascore:an accurate validated predictor of liver fibrosis in chronic hepatitis C infection[J].Clin Chem, 2005, 51 (10) :1867-1873.
|
|
[8]CALSP, OBERTI F, MICHALAK S, et al.A novel panel of blood markers to assess the degree of liver fibrosis[J].Hepatology, 2005, 42 (6) :1373-1381.
|
|
[9] ZENG MD, LU LG, MAO YM, et al.Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model[J].Hepatology, 2005, 42 (6) :1437-1445.
|
|
[10] ZHOU K, GAO CF, ZHAO YP, et al.Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B[J].J Gastroenterol Hepatol, 2010, 25 (9) :1569-1577.
|
|
[11] CALLEWAERT N, van VLIERBERGHE H, van HECKE A, et al.Noninvasive diagnosis of liver cirrhosis using DNA sequencerbased total serum protein glycomics[J].Nat Med, 2004, 10 (4) :429-434.
|
|
[12]XU MY, QU Y, JIA XF, et al.Serum proteomic MRM identify peptide ions of transferrin as new fibrosis markers in chronic hepatitis B[J].Biomed Pharmacother, 2013, 67 (7) :561-567.
|
|
[13]FRIEDRICH-RUST M, ONG MF, MARTENS S, et al.Performance of transient elastography for the staging of liver fibrosis:a meta-analysis[J].Gastroenterology, 2008, 134 (4) :960-974.
|
|
[14]Review Panel for Liver Stiffness Measurement.Recommendations for the clinical application of transient elastograph in liver fibrosis assessment[J].Chin J Hepatol, 2013, 21 (6) :420-424. (in Chinese) 肝脏硬度评估小组.瞬时弹性成像技术诊断肝纤维化专家意见[J].中华肝脏病杂志, 2013, 21 (6) :420-424.
|
|
[15]SEIMIYA M, OHNO S, YAMAMOTO H, et al.Child-Pugh score is altered by the albumin measurement method[J].Hepatology, 2013, 57 (5) :2093-2094.
|
|
[16]Joint Research Group for Major Project in the Twelfth Five-Year Plan Supported by China Ministry of Science and Technology.Comprehensive management of clinical diagnosis, assessment, and antiviral treatment of HBV-related liver cirrhosis[J].Chin J Dig, 2014, 34 (2) :77-84. (in Chinese) 科技部十二五重大专项联合课题组.乙型肝炎病毒相关肝硬化的临床诊断、评估和抗病毒治疗的综合管理[J].中华消化杂志, 2014, 34 (2) :77-84.
|
|
[17]VIZZUTTI F, ARENA U, ROMANELLI RG, et al.Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis[J].Hepatology, 2007, 45 (5) :1290-1297.
|
|
[18]CHEN YP, ZHANG Q, DAI L, et al.Is transient elastography valuable for high-risk esophageal varices prediction in patients with hepatitis-B-related cirrhosis?[J].J Gastroenterol Hepatol, 2012, 27 (3) :533-539.
|
|
[19]LISOTTI A, AZZAROLI F, BUONFIGLIOLI F, et al.Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis[J].Hepatology, 2014, 59 (2) :643-650.
|
|
[20]HUO TI, WU JC, LIN HC, et al.Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis:risk factor analysis and comparison with initial MELD and Child-TurcottePugh score[J].J Hepatol, 2005, 42 (6) :826-832.
|
|
[21]RUZ-DEL-RBOL L, ACHCAR L, SERRADILLA R, et al.Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine[J].Hepatology, 2013, 58 (5) :1732-1741.
|
|
[22] KIM WR, BIGGINS SW, KREMERS WK, et al.Hyponatremia and mortality among patients on the liver-transplant waiting list[J].N Engl J Med, 2008, 359 (10) :1018-1026.
|
DownLoad: